Quarterly ResultApr 22, 2026, 06:11 AM
Elevance Health 1Q26 Revenue $49.5B; Raises FY26 Adj. EPS to $26.75+
AI Summary
Elevance Health reported first-quarter 2026 results exceeding expectations, with operating revenue reaching $49.5 billion, a 1.5% increase year-over-year. The company raised its full-year 2026 adjusted diluted EPS guidance to at least $26.75, citing underlying business strength and improved visibility. Despite a $935 million accrual for a CMS matter, strong operating cash flow and capital returns to shareholders underscore a positive outlook.
Key Highlights
- 1Q 2026 operating revenue was $49.5 billion, up 1.5% from 1Q 2025.
- 1Q 2026 adjusted diluted EPS was $12.58.
- FY 2026 adjusted diluted EPS guidance raised to at least $26.75.
- Operating cash flow for 1Q 2026 was $4.3 billion, up $3.3 billion YoY.
- Returned $1.5 billion to shareholders via share repurchases in 1Q 2026.